These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11954156)

  • 21. Fatal outcome of nevirapine-associated toxic epidermal necrolysis.
    Leng K; Lonsdorf A; Hartmann M
    Int J STD AIDS; 2008 Sep; 19(9):642-3. PubMed ID: 18725560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nevirapine-associated toxicity.
    Imperiale M
    AIDS Read; 2002 Apr; 12(4):171. PubMed ID: 12071188
    [No Abstract]   [Full Text] [Related]  

  • 23. Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: authors' reply.
    Phillips E; Hayden A; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS
    AIDS; 2008 Feb; 22(4):548-9. PubMed ID: 18301076
    [No Abstract]   [Full Text] [Related]  

  • 24. Stuck.
    Seibert C
    Ann Intern Med; 2003 May; 138(9):765-6. PubMed ID: 12729434
    [No Abstract]   [Full Text] [Related]  

  • 25. Nevirapine-induced Stevens-Johnson syndrome in a pediatric patient.
    Mason AR; Cortes GY; Pollack RB
    Pediatr Dermatol; 2008; 25(1):128-9. PubMed ID: 18304177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of nevirapine, compared with lamivudine, on lipids and lipoproteins in HIV-1-uninfected newborns: the stopping infection from mother-to-child via breast-feeding in Africa lipid substudy.
    Sankatsing RR; Wit FW; Pakker N; Vyankandondera J; Mmiro F; Okong P; Kastelein JJ; Lange JM; Stroes ES; Reiss P
    J Infect Dis; 2007 Jul; 196(1):15-22. PubMed ID: 17538878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus-infected boy with Stevens-Johnson syndrome caused by nevirapine.
    Tebruegge M; Ritz N; Connell T; Curtis N
    Pediatr Infect Dis J; 2008 Nov; 27(11):1041-2. PubMed ID: 18833024
    [No Abstract]   [Full Text] [Related]  

  • 28. [Combined antiretroviral therapy with nevirapine of HIV-infected adults].
    Kravchenko AV
    Ter Arkh; 2004; 76(11):68-71. PubMed ID: 15658542
    [No Abstract]   [Full Text] [Related]  

  • 29. Needlestick Prevention Bill unanimously passes Senate.
    Daley K
    Ohio Nurses Rev; 2000 Mar; 75(3):7-8. PubMed ID: 12017714
    [No Abstract]   [Full Text] [Related]  

  • 30. Case studies on nonoccupational postexposure HIV prophylaxis.
    Urbina BY; Merchant RC; Mayer KH
    Med Health R I; 2003 Jun; 86(6):175-7. PubMed ID: 12973889
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment after accidental blood exposure].
    Taéron C
    Rev Infirm; 2006 Nov; (125):39-40. PubMed ID: 17214228
    [No Abstract]   [Full Text] [Related]  

  • 32. Compassion in medicine.
    Wyner LM
    W V Med J; 2014; 110(3):9. PubMed ID: 24984398
    [No Abstract]   [Full Text] [Related]  

  • 33. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
    Santos RP; Ramilo O; Barton T
    Pediatr Infect Dis J; 2007 Nov; 26(11):1053-6. PubMed ID: 17984815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Reliable effectiveness for years with good long-term tolerance: 10 years nevirapine--a summary].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():70. PubMed ID: 19024921
    [No Abstract]   [Full Text] [Related]  

  • 35. Needlestick injuries. US nurse needles congress.
    Nurs Times; 2000 Jul 13-19; 96(28):8. PubMed ID: 11963159
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV--a personal perspective.
    Veres N
    SADJ; 2000 Dec; 55(12):662-3. PubMed ID: 12608233
    [No Abstract]   [Full Text] [Related]  

  • 37. [Reliability: nevirapine. Highly effective + favorable influence on lipid profile].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():42-3. PubMed ID: 16385872
    [No Abstract]   [Full Text] [Related]  

  • 38. Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects.
    Sanne I; Mommeja-Marin H; Hinkle J; Bartlett JA; Lederman MM; Maartens G; Wakeford C; Shaw A; Quinn J; Gish RG; Rousseau F
    J Infect Dis; 2005 Mar; 191(6):825-9. PubMed ID: 15717255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.
    Phillips E; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS
    AIDS; 2007 Jul; 21(12):1561-8. PubMed ID: 17630551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nevirapine and methadone withdrawal.
    AIDS Patient Care STDS; 1999 Aug; 13(8):504. PubMed ID: 10800532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.